0000000000075154

AUTHOR

Christian Thomas

showing 47 related works from this author

Trend analysis and regional tumor incidence in Germany for testicular cancer between 2003 and 2014

2019

BACKGROUND Testicular germ cell tumor (TGCT) is one the most common solid tumors in men between the age of 15 and 35 with an overall incidence rate of 1-1.5 %. Epidemiologic studies have demonstrated different incidence patterns in western civilized countries with overall rising incidence trends. OBJECTIVE To analyze differences in regional tumor incidence rates for TGCT and perform a trend analysis for TGCT between 2003 and 2014 in Germany. MATERIAL AND METHODS TGCT cases in Germany which were diagnosed between 2003 and 2014 were provided by the Robert-Koch-Institute, Berlin. For statistical analysis, cluster and spatial scan tests according to Kulldorff were used for cases with seminoma a…

AdultMaleOncologymedicine.medical_specialtyTumor incidenceAdolescentendocrine system diseasesUrologyEndocrinology Diabetes and MetabolismTesticular Germ Cell Tumorurologic and male genital diseasesYoung Adult03 medical and health sciences0302 clinical medicineEndocrinologyTesticular NeoplasmsGermanyStatistical significanceInternal medicineEpidemiologymedicineHumansChildTesticular cancerAgedAged 80 and over030219 obstetrics & reproductive medicinebusiness.industryIncidenceIncidence (epidemiology)SeminomaMiddle AgedNeoplasms Germ Cell and Embryonalmedicine.diseaseSeminomaTrend analysisReproductive MedicinebusinessAndrology
researchProduct

Robot-assisted laparoscopic bladder diverticulectomy

2012

medicine.medical_specialtybusiness.industryUrologymedicineRobotbusinessSurgeryBJU International
researchProduct

MP-02.13 Oncological Long-Term Outcome of Patients Presenting With Chromophobe in Comparison to Non-chromophobe Renal Cell Carcinoma

2011

Oncologymedicine.medical_specialtybusiness.industryUrologyInternal medicineChromophobe Renal Cell CarcinomamedicineChromophobe cellbusinessUrology
researchProduct

Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned

2016

Nine out of ten metastatic prostate cancer (PCa) patients will develop osseous metastases. Of these, every second will suffer from skeletal-related events (SRE). SRE are associated with an increased risk for death, which is markedly increased in the presence of pathological fracture. Moreover, health insurance costs nearly double in the presence of SRE. Zoledronic acid and denosumab are both approved drugs for the prevention or delay of SRE in castration-resistant prostate cancer (CRPC) patients with osseous metastases. However, long-term treatment with one of these two drugs is associated with the development of medication-related osteonecrosis of the jaw (MRONJ). Routine inspections of th…

Oncologymedicine.medical_specialtyReview03 medical and health sciencesProstate cancerzoledronic acid0302 clinical medicineInternal medicinemedicineStage (cooking)General DentistryPathologicalmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)osteonecrosisdenosumab030206 dentistrymedicine.diseaseprostate cancerSurgerylcsh:RK1-715Zoledronic acidDenosumabBone scintigraphy030220 oncology & carcinogenesislcsh:DentistrybusinessOsteonecrosis of the jawmedicine.drugDentistry Journal
researchProduct

UP-01.160 Long-Term Follow-Up Is Necessary for Patients Presenting With pT1 and pT2 Renal Cell Carcinoma

2011

medicine.medical_specialtyLong term follow upbusiness.industryRenal cell carcinomaUrologymedicinebusinessmedicine.diseaseSurgeryUrology
researchProduct

Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients.

2016

Introduction Monocyte associated transketolase-like 1 (TKTL1) as a cancer biomarker has become popular with alternative practitioners, but plays no role in conventional medicine. This investigation evaluates the potential of serum TKTL1 as a biomarker for prostate cancer. Material and methods Patients (n = 66) undergoing curative radical prostatectomy (RPE) for biopsy-pro-ven PCa were included in the study. Controls (n = 10) were healthy, age-matched, male volunteers. 10 ml of peripheral blood was drawn from patients several days before surgery and from controls. Serum TKTL1 was measured using the ELISA method. Results The median age at tumor diagnosis was 66 years and median serum PSA was …

Conventional medicineOncologymedicine.medical_specialtydiagnosismedicine.medical_treatmentTKTL102 engineering and technologyGastroenterology03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicineTumor stagemedicinecomplementary medicineElisa methodOriginal PaperProstatectomybusiness.industryMonocyteGleason SumGeneral Medicine021001 nanoscience & nanotechnologymedicine.diseaseprostate cancerPeripheral bloodmedicine.anatomical_structure030220 oncology & carcinogenesisbiomarker0210 nano-technologybusinessCentral European journal of urology
researchProduct

The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy.

2005

Iron balance is regulated by the rate of erythropoiesis and the size of the iron stores. Anemia that accompanies infection, inflammation, and cancer (anemia of chronic disease) features normal or increased iron stores, although patients may have functional iron deficiency, namely, an imbalance between iron requirements of the erythroid marrow and the actual supply. The proportion of hypochromic red cells and the hemoglobin content of reticulocytes are direct indicators of functional iron deficiency. Biochemical markers, especially the soluble transferrin receptor/log ferritin ratio (ferritin index), are useful indicators of the iron supply to erythropoiesis. The relationship between functio…

Cancer Researchmedicine.medical_specialtyAnemiaIronInternal medicinemedicineHumansErythropoiesisErythropoietinSoluble transferrin receptorbiologyAnemia Iron-Deficiencybusiness.industryEpoetin alfaHematologyGeneral MedicineIron deficiencyIron Deficienciesmedicine.diseaseRecombinant ProteinsFerritinEpoetin AlfaEndocrinologyOncologyImmunologybiology.proteinErythropoiesisHemoglobinbusinessBiomarkersAnemia of chronic diseasemedicine.drugMedical oncology (Northwood, London, England)
researchProduct

Intraoperative peripheral frozen sections do not significantly affect prognosis after nerve-sparing radical prostatectomy for prostate cancer

2010

Study Type – Therapy (outcomes research) Level of Evidence 2b What’s known on the subject? and What does the study add? We hypothesized that taking intraoperative frozen section (FS) biopsies of the peripheral margins of resection during radical prostatectomy would allow an intraoperative systematic scan of resection margins. In the case of positive FS, extended resection could be performed with the aim of completely excising residual tumour, improving biochemical recurrence-free survival of patients with positive surgical margins at the inked specimen. To our knowledge, the prognostic value of achieving a negative resection status by systematically taking intraoperative FS of the periphera…

Biochemical recurrencemedicine.medical_specialtybusiness.industryProstatectomyUrologymedicine.medical_treatmentSurgeryNeck of urinary bladderProstate-specific antigenMedicineProstate neoplasmProstate surgeryPositive Surgical MarginStage (cooking)businessBJU International
researchProduct

Diagnosis and surgical management of colovesical fistulas due to sigmoid diverticulitis.

2009

Diverticular disease of the colon is the most frequent cause of colovesical fistulas. In this study we evaluated the accuracy of different diagnostic procedures for the detection of colovesical fistula and the clinical outcome in a series of 49 patients who underwent surgery for colovesical fistula due to sigmoid diverticulitis.Between 1982 and 2007, 42 men and 7 women underwent surgery for colovesical fistula due to sigmoid diverticulitis. Preoperative diagnostic procedures included the poppy seed test, abdominopelvic computerized tomography, magnetic resonance tomography of the abdomen, cystogram, retrograde colonic enema, urethrocystoscopy and colonoscopy.All patients had urinary tract i…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentDiverticulitis ColonicFecaluriamedicineIntestinal FistulaDysuriaHumansAgedAged 80 and overPneumaturiaSigmoid DiseasesPoppy seed testbusiness.industryEnemaDiverticulitisMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureDiverticular diseaseAbdomenFemaleRadiologymedicine.symptombusinessThe Journal of urology
researchProduct

UP-01.148 E2EPF as an Ubiquitin Carrier Protein Plays a Role in the Cancer Genesis of Papillary Renal Cell Carcinoma

2011

Pathologymedicine.medical_specialtyPapillary renal cell carcinomasUbiquitinbiologyCarrier proteinbusiness.industryUrologybiology.proteinmedicineCancermedicine.diseasebusinessUrology
researchProduct

CT-guided nephrostomy–An expedient tool for complex clinical scenarios

2018

Abstract Introduction & objectives Percutaneous nephrostomy [ 1 ] has emerged as a pivotal approach in the therapeutic management of the obstructed urinary tract. A consecutive incorporation of ultrasonic and radiographic guidance, the approach experienced an almost ubiquitious distribution while most centers currently applying either one or both of these tools jointly. However, success of ultrasound-guidance is limited in obese patients and non-dilated uropathy. In turn, fluoroscopy usually requires an opacification of the urinary collecting system by intravenous or antegrade contrast media injection, which might be harmful for already impaired renal function, raise intrapelvic pressure an…

MaleUrologic Diseasesmedicine.medical_specialtySupine positionUrinary systemmedicine.medical_treatmentKidneyRadiography Interventional030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineUrethral DiseasesmedicineHumansRadiology Nuclear Medicine and imagingObesityRenal InsufficiencyObstructive uropathyUltrasonography InterventionalAgedNephrostomy PercutaneousRetrospective Studiesbusiness.industryMortality rateGeneral MedicineOverweightmedicine.diseaseSurgeryProne positionSurgery Computer-AssistedPercutaneous nephrostomyFluoroscopy030220 oncology & carcinogenesisFeasibility StudiesFemaleMedian bodyTomography X-Ray ComputedbusinessComplicationAnesthesia LocalDilatation PathologicEuropean Journal of Radiology
researchProduct

Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer.

2019

To compare toxicity and response of docetaxel chemotherapy between metastatic hormone-sensitive prostate cancer (mHSPC) and castration-resistant metastatic prostate cancer (mCRPC) patients of the same therapeutic era for assessing of upfront docetaxel against the benchmark of docetaxel in the castrate resistant stage in the setting outside of clinical trials.A prospectively collected database of real-world prostate cancer patients receiving docetaxel was divided in mHSPC and mCRPC cases and retrospectively analyzed. Principal objectives were toxicity measured by the common criteria of adverse events terminology and response characterized by Prostate specific antigen decline and radiographic…

OncologyMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsUrologymedicine.medical_treatment030232 urology & nephrologyAntineoplastic AgentsDocetaxelSeverity of Illness Index03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicinemedicineHumansProspective StudiesStage (cooking)Adverse effectAgedNeoplasm StagingRetrospective StudiesChemotherapyPerformance statusbusiness.industryProstateMiddle AgedProstate-Specific Antigenmedicine.diseasePrognosisProgression-Free SurvivalClinical trialRadiographyProstate-specific antigenProstatic Neoplasms Castration-ResistantOncologyDocetaxelClinical Trials Phase III as Topic030220 oncology & carcinogenesisDisease ProgressionKallikreinsbusinessmedicine.drugUrologic oncology
researchProduct

MP-03.04 The Combination Treatment of Bicalutamide Plus Carbidopa Significantly Enhances the in vivo Antitumor Activity on LNCaP Castration-resistant…

2011

Antitumor activityOncologyDrugmedicine.medical_specialtyBicalutamidebusiness.industryUrologymedia_common.quotation_subjectmedicine.diseaseProstate cancerIn vivoInternal medicineCarbidopaLNCaPmedicineCancer researchbusinessTumor xenograftmedicine.drugmedia_commonUrology
researchProduct

Nationwide analysis on the impact of socioeconomic land use factors and incidence of urothelial carcinoma

2017

Incidence rates for urothelial carcinoma (UC) have been reported to differ between countries within the European Union (EU). Besides occupational exposure to chemicals, other substances such as tobacco and nitrite in groundwater have been identified as risk factors for UC. We investigated if regional differences in UC incidence rates are associated with agricultural, industrial and residential land use.Newly diagnosed cases of UC between 2003 and 2010 were included. Information within 364 administrative districts of Germany from 2004 for land use factors were obtained and calculated as a proportion of the total area of the respective administrative district and as a smoothed proportion. Fur…

AdultMale0301 basic medicineUrologic NeoplasmsCancer ResearchMultivariate analysisAdolescentEpidemiologyYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsGermanyHumansIndustryMedicinemedia_common.cataloged_instanceYoung adultEuropean unionChildSocioeconomic statusAgedmedia_commonAged 80 and overLand usebusiness.industryIncidenceIncidence (epidemiology)SmokingAgricultureEnvironmental ExposureEnvironmental exposureMiddle Aged030104 developmental biologySocioeconomic FactorsOncologyAdministrative District030220 oncology & carcinogenesisFemalebusinessDemographyCancer Epidemiology
researchProduct

Risk factors, complications and management of lymphocele formation after radical prostatectomy: A mini‐review

2019

Lymphocele formation is the most common adverse event of pelvic lymphadenectomy during radical prostatectomy for prostate cancer. Previous studies failed to favor one surgical technique over the other in terms of minimizing its rate. Data on risk factors for its development are still conflicting and warranting further research. In this mini-review, we aimed to scrutinize available evidence on these aspects and outline current achievements in lymphocele prevention approaches.

Malemedicine.medical_specialtyLymphoceleUrologymedicine.medical_treatment030232 urology & nephrologyPelvisMini review03 medical and health sciencesLymphoceleProstate cancer0302 clinical medicineRisk FactorsHumansMedicineAdverse effectPelvic lymphadenectomyProstatectomybusiness.industryProstatectomyGeneral surgeryProstatic Neoplasmsmedicine.disease030220 oncology & carcinogenesisLymph Node ExcisionbusinessInternational Journal of Urology
researchProduct

Predictors for clinically relevant Gleason score upgrade in patients undergoing radical prostatectomy

2011

Study Type – Diagnostic (exploratory cohort) Level of Evidence 2b What’s known on the subject? and What does the study add? Clinically relevant GSU in the prostatectomy specimen is a common phenomenon. Clinically relevant GSU occurs in one of three patients with clinically ‘very’ low-risk PCa, and a low number of biopsy cores is the key negative predictor. OBJECTIVE • To evaluate clinical predictors for Gleason score upgrade (GSU) in radical prostatectomy (RP) specimen, especially in patients with ‘very’ low risk PCA (T1c and biopsy Gleason score ≤6 and PSA <10 ng/ml and ≤2 positive biopsy cores and PSA density <0.15). Patients and Methods • 402 consecutive patients undergoing RP between 20…

medicine.medical_specialtyProstate biopsymedicine.diagnostic_testbusiness.industryProstatectomyUrologymedicine.medical_treatmentUrologyRetrospective cohort studyurologic and male genital diseasesSurgerymedicine.anatomical_structureProstatePredictive value of testsBiopsyCohortmedicineIn patientbusinessBJU International
researchProduct

AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC

2019

&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; Androgen receptor variant 7 (AR-V7) plays an important role in the progression of castration-resistant prostate cancer (CRPC) and has shown potential as a predictive biomarker in circulating tumour cells (CTCs) isolated from the bloodstream in terms of a liquid biopsy. Studies have shown that AR-V7 is a potential surrogate for selecting drug classes for systemic treatment by detecting nuclear AR-V7 by immunofluorescence or measuring AR-V7 messenger RNA by quantitative PCR. Here, we assessed the predictive value of AR-V7 detected by classical immunohistochemistry (IHC) for treatment response. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; C…

MaleUrology030232 urology & nephrologyAntineoplastic AgentsDocetaxel03 medical and health scienceschemistry.chemical_compoundProstate cancer0302 clinical medicineCell Line TumormedicineHumansEnzalutamideProspective StudiesLiquid biopsyAgedAged 80 and overbusiness.industryAndrogen AntagonistsNeoplastic Cells CirculatingPrognosismedicine.diseaseAndrogen receptorProstatic Neoplasms Castration-ResistantTreatment OutcomeDocetaxelchemistryReceptors AndrogenCabazitaxel030220 oncology & carcinogenesisCancer researchBiomarker (medicine)ImmunohistochemistryTaxoidsbusinessmedicine.drugUrologia Internationalis
researchProduct

Systemic treatment of bone metastases in castration-resistant prostate cancer (CRPC): pre-clinical to clinical point of view

2015

Abstract Prostate cancer (PCa) is the most common cancer and the third most common cause of cancer related mortality in men in the United States. Hormonal therapy remains the most effective therapy for patients with advanced prostate cancer, inhibiting proliferation and inducing apoptosis in tumor cells. Unfortunately, after short-term remissions (18–24 months), surviving tumor cells recur with castrate resistant prostate cancer (CRPC) with inevitable progression, development of metastases mainly in bone, and death within 2–3 years in most men. Improved understanding of the molecular basis underlying bone-specific metastases and resistance to ADT or chemotherapy will facilitate the rational…

Oncologymedicine.medical_specialtyChemotherapyStromal cellbusiness.industrymedicine.medical_treatmentCancerDiseasemedicine.diseaseExtracellular matrixClinical trialProstate cancerInternal medicinemedicineHormonal therapybusiness
researchProduct

Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.

2008

We determined indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.Of 316 cystoprostatectomy specimens concomitant prostate cancer was diagnosed in 21.5%. Prostate cancer was diagnosed preoperatively in 24% of cases (evident prostate cancer), 32% were suspicious for prostate cancer but no biopsy was done (suspected prostate cancer) and in 44% prostate cancer was incidental. Patients were stratified into probability groups of intermediate/high risk prostate cancer by digital rectal examination and prostate specific antigen. The incidence of unfavorable histopathology was determined in each group.Of prostate cancers 85% were organ c…

Malemedicine.medical_specialtyProstate biopsyUrologymedicine.medical_treatmentUrologyCystectomyRisk AssessmentCystoprostatectomyCohort StudiesProstate cancerProstatePredictive Value of TestsPreoperative CaremedicineHumansAgedNeoplasm StagingRetrospective StudiesAged 80 and overProstatectomyCarcinoma Transitional CellUrinary bladderBladder cancermedicine.diagnostic_testbusiness.industryBiopsy NeedleProstateCancerProstatic NeoplasmsNeoplasms Second PrimaryMiddle AgedProstate-Specific Antigenmedicine.diseaseCombined Modality TherapyImmunohistochemistrySurvival AnalysisProstate-specific antigenmedicine.anatomical_structureTreatment OutcomeUrinary Bladder NeoplasmsbusinessFollow-Up StudiesThe Journal of urology
researchProduct

Ruptured angiomyolipoma of the kidney: a rare differential diagnosis of flank pain.

2017

Angiomyolipomas (AMLs) of the kidney are typically benign and rare, with an incidence of 2% of all renal masses [1]. They are associated with tuberous sclerosis in about 20% of cases. If ruptured, ...

AdultMalemedicine.medical_specialtyAngiomyolipomaFlank painUrologyAngiomyolipoma030232 urology & nephrologyUreteral stoneFlank PainDiagnosis Differential03 medical and health sciencesTuberous sclerosis0302 clinical medicinemedicineHumansKidneyRupture Spontaneousbusiness.industryIncidence (epidemiology)food and beveragesmedicine.diseaseKidney NeoplasmsSurgeryTomography x ray computedmedicine.anatomical_structureNephrology030220 oncology & carcinogenesisRadiologyDifferential diagnosisbusinessTomography X-Ray ComputedScandinavian journal of urology
researchProduct

Continent Anal Urinary Diversion in Classic Bladder Exstrophy: 45-Year Experience

2017

Objective To evaluate the long-term outcomes in patients with classic bladder exstrophy and continent anal urinary diversion (CAD) for continence, upper urinary tract status, secondary malignancies, and sexual function. Patients and Methods The medical records of 82 exstrophy patients having undergone CAD in our department between 1970 and 2015 were reviewed. Patients were invited for follow-up examinations and asked to complete validated questionnaires relating to sexual function. Results Thirty-two of 57 eligible patients with a median follow-up of 23.9 years were included in the study. Ninety-seven percent of patients were fully continent during daytime. Upper urinary tract and renal fun…

AdenomaAdultMalemedicine.medical_specialtyTime FactorsSexual BehaviorUrologymedicine.medical_treatmentUrinary system030232 urology & nephrologyAdenocarcinomaUrinary DiversionYoung Adult03 medical and health sciencesPostoperative Complications0302 clinical medicineSurveys and QuestionnairesInternal medicinemedicineHumansRetrospective StudiesUpper urinary tractmedicine.diagnostic_testbusiness.industryMedical recordBladder ExstrophyUrinary Reservoirs ContinentUrinary diversionMiddle Agedmedicine.diseaseSurgeryEndoscopyBladder exstrophyTreatment OutcomeSexual dysfunctionUrinary Bladder Neoplasms030220 oncology & carcinogenesisColonic NeoplasmsFemalemedicine.symptombusinessSexual functionFollow-Up StudiesUrology
researchProduct

Nephron-sparing surgery versus radical nephrectomy for kidney tumors: benefits and limitations

2011

medicine.medical_specialtyKidneybusiness.industrymedicine.medical_treatmentUrologymedicine.diseaseNephrectomymedicine.anatomical_structureOncologyRenal cell carcinomamedicinePharmacology (medical)Nephron sparing surgerybusinessExpert Review of Anticancer Therapy
researchProduct

Sexual Function and Fertility of Women with Classic Bladder Exstrophy and Continent Urinary Diversion

2015

We evaluated the outcome in female patients with classic bladder exstrophy and continent urinary diversion for sexual function and fertility.We reviewed the medical records of female exstrophy patients who underwent continent urinary diversion in our department between 1969 and 2014. Patients were invited for followup examination and asked to complete questionnaires relating to sexual function, social integration and maternity.Of 38 eligible patients 29 (response rate 76%) with a followup of 22.3 years were included in study. Primary continent urinary diversion was done in 62% of patients and 38% underwent secondary continent urinary diversion after failed reconstruction of the exstrophic b…

Adultmedicine.medical_specialtyUrologymedicine.medical_treatmentmedia_common.quotation_subject030232 urology & nephrologyFertilityHuman sexualityUrinary DiversionPelvic Organ Prolapse03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsmedicineHumansRetrospective Studiesmedia_common030219 obstetrics & reproductive medicinebusiness.industryIncidenceGeneral surgeryBladder ExstrophyUrinary Reservoirs ContinentUrinary diversionRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryBladder exstrophySexual Dysfunction PhysiologicalTreatment OutcomeSexual dysfunctionFemalemedicine.symptomSexual functionbusinessInfertility Femalehuman activitiesContinent Urinary DiversionFollow-Up StudiesJournal of Urology
researchProduct

Genetic profiling in der Diagnostik des hereditären Prostatakarzinoms – wo stehen wir?

2018

ZusammenfassungProstatakrebs weist im Vergleich zu anderen Tumorentitäten ein heterogenes genetisches Profil auf. Dementsprechend sind auch Mutationen, die das Prostatakarzinomrisiko erhöhen, vielfältig. Manche genetische Varianten fallen bei der Risikoerhöhung nur milde ins Gewicht. Andere Genmutationen (BRCA1 /2; HOXB13) erhöhen das Risiko jedoch teils erheblich. Insgesamt ist die Wahrscheinlichkeit für einen nicht familiär vorbelasteten Mann, ein Träger von Mutationen zu sein, welche mit einem erhöhten PCa-Risiko assoziiert sind, niedrig. Ist aber die familiäre Belastung durch in jungem Alter erkrankte Verwandte oder eine bereits bekannte Mutation in der Familie vorhanden, so steigt auch…

Gynecology03 medical and health sciencesmedicine.medical_specialty0302 clinical medicinebusiness.industry030220 oncology & carcinogenesisUrology030232 urology & nephrologyMedicinebusinessAktuelle Urologie
researchProduct

Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically …

2009

OBJECTIVE To evaluate the expression of urokinase-plasminogen-activator receptor (uPA-R) in disseminated tumour cells (DTC) in bone marrow (BM) and peripheral blood (PB) of patients with clinically localized prostate cancer before radical prostatectomy (RP), and to assess the associations with pathological variables and prognosis. PATIENTS AND METHODS In all, 52 patients (47 with clinically localized cancer and five with benign prostatic hyperplasia, BPH, as controls) were prospectively enrolled. BM and PB samples were drawn before surgery. DTC were enriched using a commercial system, cytokeratin (CK) 8/18 was used to detect DTC, and uPA-R expression was detected by dual-immunostaining of t…

Malemedicine.medical_specialtyPathologyUrologyReceptor expressionmedicine.medical_treatmentGastroenterologyReceptors Urokinase Plasminogen ActivatorCytokeratinProstate cancerBone MarrowInternal medicinemedicineBiomarkers TumorHumansAgedProstatectomybusiness.industryProstatectomyCancerProstatic NeoplasmsHyperplasiaMiddle AgedProstate-Specific Antigenmedicine.diseaseNeoplastic Cells CirculatingPrognosisImmunohistochemistryUrokinase receptormedicine.anatomical_structureLymphatic MetastasisBone marrowNeoplasm Recurrence LocalbusinessEpidemiologic MethodsBJU international
researchProduct

256 Functional analysis of elective nephron-sparing surgery versus radical nephrectomy for renal tumors larger than 4 cm

2012

Objective To preserve renal function, nephron sparing surgery (NSS) for renal tumors should be performed. Little is known about perioperative morbidity and long-term functional outcome of patients after elective NSS compared with radical nephrectomy (RN) in renal tumors >4 cm. Materials and Methods Eight-hundred twenty-nine patients were treated with either RN (n = 641) or NSS (n = 188) for renal tumors >4 cm. After pairing the cohort for age, grading, TNM, size, gender, and preoperative renal function and excluding patients with imperative indication and metastases, 247 patients remained for functional analysis. Serum creatinine (SCr) values were used to estimate glomerular filtration rate…

Creatininemedicine.medical_specialtybusiness.industryUrologymedicine.medical_treatmentUrologyRenal functionPerioperativeurologic and male genital diseasesmedicine.diseaseNephrectomySurgerychemistry.chemical_compoundchemistryCohortmedicineComplicationbusinessGrading (tumors)Kidney diseaseEuropean Urology Supplements
researchProduct

DHH is an independent prognosticator of oncologic outcome of clear cell renal cell carcinoma.

2014

Aberrant HH signaling has proved important in the pathogenesis of several solid cancers. Limited in vitro analyses suggested an oncogenic role for HH in renal cell carcinoma. In this explorative study we sought to validate aberrant HH expression in patients with renal cell carcinoma.A tissue microarray was constructed from 140 radical nephrectomy specimens of patients with clear cell renal cell carcinoma. We performed immunohistochemistry for Ki67 and HH pathway biomarkers, including PTCH1, Smo, SHH, IHH, DHH, Gli1, Gli2 and Gli3. Staining intensity was measured by automated image processing and related to tumor stage and grade. The impact of biomarker expression on cancer specific survival…

MalePathologymedicine.medical_specialtyUrologymedicine.medical_treatmentRenal cell carcinomamedicineCarcinomaHumansHedgehog ProteinsCarcinoma Renal CellDesert hedgehogAgedRetrospective StudiesKidneyTissue microarraybusiness.industryMiddle Agedmedicine.diseasePrognosisNephrectomyKidney NeoplasmsClear cell renal cell carcinomamedicine.anatomical_structurePTCH1Cancer researchFemalebusinessThe Journal of urology
researchProduct

Perioperatives Outcome in Korrelation zur Lernkurve bei robotisch assistierter partieller Nephrektomie: Die ersten 109 Fälle unserer Klinik

2015

Hintergrund: Die robotisch assistierte partielle Nephrektomie (RAPN) zeigt im Gegensatz zur konventionellen laparoskopischen Nierenteilresektion eine steile Lernkurve und kurzere warme Ischamiezeiten (WIZ). Dies ermoglicht es Patienten mit einem Nierentumor im Stadium cT1a, bei vergleichbaren onkologischen Ergebnissen, die Vorteile eines minimalinvasiven Operationsverfahrens zukommen zu lassen. Ziel der vorliegenden Studie war es, das perioperative Outcome unserer Patienten nach RAPN zu untersuchen und die Lernkurve anhand charakteristischer Werte, wie z. B. der WIZ, zu illustrieren. Material und Methode: Die Daten von 109 Patienten, die in unserer Klinik von Januar 2010 bis April 2015 eine…

Gynecologymedicine.medical_specialtybusiness.industryUrologyMedicinebusinessAktuelle Urologie
researchProduct

Anaemia in the critically ill patient: monitoring of erythropoietin therapy

2006

Nephrologymedicine.medical_specialtyRemote patient monitoringAnemiaCritical IllnessUrologyTreatment outcomeInternal medicinemedicineHumansErythropoiesisIntensive care medicineErythropoietinAnemia Iron-DeficiencyDose-Response Relationship DrugCritically illbusiness.industrymedicine.diseaseRecombinant ProteinsSurgeryTreatment OutcomeIron-deficiency anemiaErythropoietinErythropoietin therapyHematinicsDrug Monitoringbusinessmedicine.drugBJU International
researchProduct

Treatment of cT1a Renal Tumours in Germany: A Nationwide Survey.

2015

&lt;b&gt;&lt;i&gt;Objective:&lt;/i&gt;&lt;/b&gt; To identify clinical parameters influencing German urologists treating cT1a renal tumours, we performed a nationwide survey among members of the German urological associations (DGU and BDU). &lt;b&gt;&lt;i&gt;Material and Methods:&lt;/i&gt;&lt;/b&gt; In spring 2012, DGU and BDU members were invited to complete our survey. For 8 cases and 3 index patients, participants were asked about their preferred treatment. Multivariate analyses were used to identify significant parameters leading the responders to favour radical nephrectomy (RN) over nephron sparing surgery (NSS) as well as active surveillance (AS) over invasive treatment. &lt;b&gt;&lt;i…

AdultMalemedicine.medical_specialtyMultivariate analysismedicine.medical_treatmentBiopsyUrology030232 urology & nephrologyRenal functionNationwide surveyKidneyNephrectomy03 medical and health sciencesImpaired renal function0302 clinical medicineInternal medicineGermanySurveys and QuestionnairesBiopsymedicineHumansAgedKidneymedicine.diagnostic_testbusiness.industryNephronsMiddle AgedNephrectomyKidney NeoplasmsSurgerymedicine.anatomical_structure030220 oncology & carcinogenesisMultivariate AnalysisFemaleNephron sparing surgerybusinessTomography X-Ray ComputedUrologia internationalis
researchProduct

Incidence of Cardiovascular Events after Nephrectomy - A Single Centre, Matched Pair Analysis between Donor and Tumour Nephrectomy in a Long Term Fol…

2016

&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; The study aimed to compare the incidence of cardiovascular events (CVEs) after donor nephrectomy (DN) and radical tumor nephrectomy (RN), according to an estimated glomerular filtration rate (eGFR), were evaluated over time. &lt;b&gt;&lt;i&gt;Materials and Methods:&lt;/i&gt;&lt;/b&gt; Follow-up was collected for DN who underwent surgery from 1998 to 2007 for CVE and renal function. All DN were matched for age to patients treated by RN or adenoma enucleation (control group), who were eligible for DN. eGFR was estimated using the Cockgroft-Gould formula. Patients with preoperative comorbidities were excluded. &lt;b&gt;&lt;i&gt;Results:&lt;/i…

AdultMalemedicine.medical_specialtyTime FactorsAdenomaUrologymedicine.medical_treatmentMatched-Pair AnalysisEnucleation030232 urology & nephrologyUrologyRenal functionNephrectomy03 medical and health sciences0302 clinical medicinePostoperative ComplicationsInterquartile rangemedicineHumans030212 general & internal medicineRisk factorStrokebusiness.industryIncidence (epidemiology)IncidenceMiddle Agedmedicine.diseaseNephrectomyKidney NeoplasmsTissue DonorsSurgeryCardiovascular DiseasesFemalebusinessFollow-Up StudiesUrologia internationalis
researchProduct

Sexual Function, Social Integration and Paternity of Males with Classic Bladder Exstrophy following Urinary Diversion.

2015

We evaluated patients with classic bladder exstrophy and a history of urinary diversion for sexual function, social integration and paternity.We reviewed the medical records of males older than 18 years with exstrophy who had undergone urinary diversion at our department between 1969 and 2014. Patients were invited for structured followup examinations and were asked to complete questionnaires relating to sexual function, social integration and paternity.Of 79 eligible patients 39 (49%) with a mean followup of 23.8 years (range 2 to 45) were included in the study. Of the patients 41% had undergone primary urinary diversion and 59% had undergone secondary urinary diversion after failed recons…

AdultMalemedicine.medical_specialtyPediatricsUrologymedia_common.quotation_subjectmedicine.medical_treatment030232 urology & nephrologyFertilityPaternityUrinary DiversionMale infertility03 medical and health sciences0302 clinical medicineErectile DysfunctionSurveys and QuestionnairesMedicineHumansSocial BehaviorInfertility Malemedia_commonbusiness.industryMedical recordUrinary diversionBladder ExstrophyMiddle Agedmedicine.diseaseSurgeryBladder exstrophyErectile dysfunctionSexual dysfunction030220 oncology & carcinogenesismedicine.symptomSexual functionbusinessThe Journal of urology
researchProduct

Robot-Assisted Transvesical Enucleation of Benign Prostatic Hyperplasia: Lessons from a Single Surgeon’s Learning Curve

2014

Abstract Introduction Open simple prostatectomy is a well-established and effective operation for prostate volumes greater than 80 gm but also associated with bleeding and urinary incontinence. To benefit from the advances of laparoscopy, robot-assisted simple prostatectomy was established. We determined the learning curve of this minimally invasive surgery by evaluating the first procedures by an experienced robotic surgeon. Methods Patients presenting for surgical therapy with prostate volumes greater than 80 gm were considered for the study. Evaluation included validated questionnaires preoperatively, and at 6 and 12 weeks postoperatively. Blood loss, transfusions, operation time and pad…

medicine.medical_specialtymedicine.diagnostic_testProstatectomybusiness.industryUrologymedicine.medical_treatmentEnucleationUrologyUrinary incontinenceSurgerymedicine.anatomical_structureQuality of lifeProstatemedicineInternational Prostate Symptom Scoremedicine.symptombusinessLaparoscopyTransurethral resection of the prostateUrology Practice
researchProduct

sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro

2019

Abstract Introduction Cadherin family proteins are involved in the tumorigenesis of several malignancies. However, their significance in renal cell carcinoma (RCC) has not been extensively investigated. The current study investigates the potential of several cadherins to perform as biomarkers for tumor detection and exert functional RCC activity. Methods Pre- and postoperative concentrations of sE-cadherin, cadherin-6, N-cadherin, cadherin-11, cadherin-17, and cadherin-5 were measured in serum of patients undergoing surgery for RCC and correlated to clinical and histopathological parameters. Control serum was obtained from healthy volunteers. A498 and Caki-1 cells were incubated with sE-cad…

AdultMaleUrologyPopulation030232 urology & nephrologymedicine.disease_cause03 medical and health sciences0302 clinical medicineDownregulation and upregulationRenal cell carcinomaBiomarkers TumorTumor Cells CulturedmedicineHumansNeoplasm InvasivenessProspective StudieseducationCarcinoma Renal CellAgedAged 80 and overeducation.field_of_studyCadherinCell growthbusiness.industryChemotaxisMiddle AgedCadherinsmedicine.diseaseKidney NeoplasmsUp-RegulationOncology030220 oncology & carcinogenesisCancer cellCancer researchFemaleCarcinogenesisbusinessUrologic Oncology: Seminars and Original Investigations
researchProduct

Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph nod…

2009

OBJECTIVE To investigate the associations between different overall or topographically restricted lymph node (LN) variables and cancer-specific survival (CSS) after radical cystectomy (RC) and extended LN dissection (LND) with curative intent in patients with LN-positive bladder cancer. PATIENTS AND METHODS Between 2001 and 2006, 152 patients had RC with standardized extended LND for bladder cancer with curative intent. Patients with positive LNs were stratified according to the median of the LN variables (LNs removed, number of positive LNs, LN density). CSS was related to overall and topographically restricted LN variables, e.g. different levels of LND, and relationships were tested by un…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyCystectomymedicineCarcinomaHumansLymph nodeAgedAged 80 and overCarcinoma Transitional CellBladder cancerbusiness.industryHazard ratioCancerMiddle AgedPrognosismedicine.diseaseConfidence intervalSurgeryTreatment Outcomemedicine.anatomical_structureUrinary Bladder NeoplasmsLymphatic MetastasisLymph Node ExcisionFemaleLymphadenectomyEpidemiologic MethodsbusinessBJU International
researchProduct

Outcome of radical prostatectomy for incidental carcinoma of the prostate

2009

OBJECTIVE To evaluate a contemporary series of patients with incidental prostate cancer detected by transurethral resection of the prostate (TURP) and undergoing radical prostatectomy (RP). PATIENTS AND METHODS Between 1998 and 2004, 1931 patients had TURP for obstructive voiding symptoms and suspected BPH. Incidental prostate cancer was found in 104 (5.4%); 26 of these patients had a RP. The pathological staging and treatment of these patients were reviewed retrospectively and the follow-up results obtained. RESULTS Of the 26 patients who had RP, 17 had T1a and nine had T1b carcinoma of the prostate. After RP, six (35%) in the T1a group had no residual tumour (pT0) and 11 (65%) had pT2 can…

Malemedicine.medical_specialtyProstate biopsyUrologymedicine.medical_treatmentPathological stagingProstatic HyperplasiaUrologyurologic and male genital diseasesProstate cancerProstatemedicineHumansAgedTransurethral resection of the prostateProstatectomyIncidental Findingsmedicine.diagnostic_testbusiness.industryProstatectomyProstatic NeoplasmsCancerMiddle AgedProstate-Specific Antigenmedicine.diseaseTreatment Outcomemedicine.anatomical_structureHormonal therapyEpidemiologic MethodsbusinessProstatismBJU International
researchProduct

Incidence, Risk Factors and Management of Symptomatic Lymphoceles after Radical Retropubic Prostatectomy

2017

Abstract Introduction We investigated the incidence, clinical course and risk factors for symptomatic lymphoceles after radical retropubic prostatectomy with pelvic lymph node dissection. Moreover, we explored parameters for the failure of percutaneous lymphocele drainage. Methods The incidence of symptomatic lymphoceles in patients with prostate cancer who underwent radical retropubic prostatectomy with pelvic lymph node dissection in our department between 2008 and 2013 was investigated retrospectively. The occurrence of lymphoceles was correlated with several clinical and histopathological parameters. In addition, logistic regression analysis was performed to assess the value of independ…

medicine.medical_specialtyPercutaneousbusiness.industryProstatectomyUrologymedicine.medical_treatment030232 urology & nephrologymedicine.diseaseSurgery03 medical and health sciencesDissectionLymphocele0302 clinical medicinemedicine.anatomical_structure030220 oncology & carcinogenesismedicineLymphRisk factorbusinessLymph nodeRadical retropubic prostatectomyUrology Practice
researchProduct

Anemia of Chronic Disease: Pathophysiology and Laboratory Diagnosis

2005

Classic iron deficiency (ID) does not represent a challenge for the laboratory and physicians. The anemia that accompanies infection, inflammation, and cancer, commonly termed anemia of chronic disease (ACD), features apparently normal or increased iron stores. However, 20% of these patients have iron-restricted erythropoiesis (functional ID), an imbalance between the iron requirements of the erythroid marrow and the actual iron supply. Functional ID leads to a reduction in red cell hemoglobiniza-tion, causing hypochromic microcytic anemia. The diagnosis of functional ID in real time is based on measuring the hemoglobin content of reticulocytes. An examination of the biochemical markers of …

AnemiaIronClinical BiochemistrymedicineHomeostasisHumansErythropoiesisErythropoietinSoluble transferrin receptorbiologybusiness.industryBiochemistry (medical)AnemiaHematologyIron deficiencymedicine.diseaseHypochromic microcytic anemiaFerritinErythropoietinChronic DiseaseImmunologybiology.proteinErythropoiesisbusinessAnemia of chronic diseasemedicine.drugLaboratory Hematology
researchProduct

Deregulation of E2-EPF Ubiquitin Carrier Protein in Papillary Renal Cell Carcinoma

2011

Molecular pathways associated with pathogenesis of sporadic papillary renal cell carcinoma (PRCC), the second most common form of kidney cancer, are poorly understood. We analyzed primary tumor specimens from 35 PRCC patients treated by nephrectomy via gene expression analysis and tissue microarrays constructed from an additional 57 paraffin-embedded PRCC samples via immunohistochemistry. Gene products were validated and further studied by Western blot analyses using primary PRCC tumor samples and established renal cell carcinoma cell lines, and potential associations with pathologic variables and survival in 27 patients with follow-up information were determined. We show that the expressio…

MalePathologymedicine.medical_specialtyMolecular Sequence DataBiologyResponse ElementsPathology and Forensic MedicineRenal cell carcinomaGene expressionmedicineCarcinomaHumansCarcinoma Renal CellTissue microarrayBase SequencePapillary renal cell carcinomasRegular ArticleHypoxia-Inducible Factor 1 alpha SubunitPrognosismedicine.diseasePrimary tumorCell HypoxiaHEK293 CellsVon Hippel-Lindau Tumor Suppressor ProteinSporadic Papillary Renal Cell CarcinomaMutationUbiquitin-Conjugating EnzymesDisease ProgressionFemaleKidney cancerThe American Journal of Pathology
researchProduct

Incidence, Clinical Symptoms and Management of Rectourethral Fistulas After Radical Prostatectomy

2009

Rectourethral fistula is a rare but severe complication after radical prostatectomy and there is no standardized treatment. We retrospectively evaluated the incidence, symptoms and management of rectourethral fistulas based on our experience.From 1999 to 2008 we performed 2,447 radical prostatectomies. Patients in whom postoperative rectourethral fistulas developed were identified. Based on the therapeutic approach patients were categorized into group 1-conservative treatment, group 2-colostomy with or without surgical closure and group 3-immediate surgical closure without colostomy.Rectourethral fistulas developed in 13 of 2,447 patients (0.53%) after radical prostatectomy. The risk of rec…

MaleNephrologymedicine.medical_specialtyUrinary FistulaUrologymedicine.medical_treatmentFistulaUrologyRectourethral fistulaInternal medicineUrethral DiseasesEpidemiologymedicineHumansRectal FistulaAgedRetrospective StudiesProstatectomyProstatectomybusiness.industryIncidenceIncidence (epidemiology)Retrospective cohort studyMiddle Agedmedicine.diseaseSurgerybusinessRetropubic prostatectomyJournal of Urology
researchProduct

Intraoperative Monitoring of Bladder and Internal Anal Sphincter Innervation: A Predictor of Erectile Function following Low Anterior Rectal Resectio…

2013

&lt;b&gt;&lt;i&gt;Background:&lt;/i&gt;&lt;/b&gt; The objective was to investigate whether two-dimensional intraoperative neuromonitoring (IONM) of pelvic autonomic nerves has the potential to predict erectile function (EF) following surgery for rectal cancer. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; A consecutive series of 17 sexually active male rectal cancer patients undergoing IONM-based nerve-sparing low anterior rectal resection were evaluated prospectively. IONM was performed by electric stimulation of the pelvic splanchnic nerves with concomitant electromyography of the internal anal sphincter and cystomanometry. Sexual function was assessed using a validated questionnaire. &l…

Malemedicine.medical_specialtyColorectal cancerUrinary BladderAnal CanalInternal anal sphincterErectile DysfunctionMonitoring IntraoperativemedicineHumansAutonomic PathwaysRectal resectionProspective StudiesProspective cohort studyDigestive System Surgical ProceduresAgedUrinary bladderRectal Neoplasmsbusiness.industryGastroenterologyAutonomic PathwaysMiddle AgedAnal canalmedicine.diseaseSurgerymedicine.anatomical_structureErectile dysfunctionSurgerybusinessOrgan Sparing TreatmentsFollow-Up StudiesDigestive Surgery
researchProduct

Clinical Scenario: Unexpected Positive Nodes at Radical Cystectomy

2014

Positive lymph nodes are found in 20–30 % of patients undergoing radical cystectomy for bladder cancer. Their presence is associated with poor survival in the majority. Super-extended lymph node dissection is recommended in the presence of positive lymph nodes to possibly improve oncologic outcome. In patients with unsuspicious lymph nodes, dissection should be performed at least up to the common iliac vessels. Even in the presence of lymph node metastases cystectomy is indicated to reduce local tumor complications. The type of urinary diversion should not be altered by lymph node positivity unless the diversion would otherwise negatively influence the extent of the procedure.

medicine.medical_specialtyBladder cancerbusiness.industrymedicine.medical_treatmentUrinary diversionmedicine.diseaseCystectomyDissectionmedicine.anatomical_structuremedicineIn patientRadiologyLymphbusinessLymph nodeClinical scenario
researchProduct

Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zole…

2008

Abstract Background In addition to other treatments, patients with prostate cancer (pCA) and bone metastasis receive bisphosphonates. Since 2003, a previously unknown side-effect of bisphosphonates—bisphosphonate-associated osteonecrosis of the jaws (BP-ONJ)—has been described, and frequency has since increased. An exact incidence is still unknown. Objectives The aim of this study was to assess the incidence and additional factors in the development of BP-ONJ. Design, setting, and participants From July 2006 to October 2007, patients with advanced pCA and osseous metastasis receiving bisphosphonate therapy in the Department of Urology or Haematology and Oncology at the Johannes-Gutenberg-Un…

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentBone NeoplasmsZoledronic AcidProstate cancerRisk FactorsInternal medicineGermanymedicinePrevalenceHumansProspective cohort studyAgedRetrospective StudiesBisphosphonate-associated osteonecrosis of the jawBone Density Conservation AgentsDiphosphonatesbusiness.industryIncidence (epidemiology)ImidazolesOsteonecrosisBone metastasisProstatic NeoplasmsRetrospective cohort studyBisphosphonateMiddle Agedmedicine.diseasePrognosisSurgeryZoledronic acidCross-Sectional StudiesInjections IntravenousbusinessJaw Diseasesmedicine.drugFollow-Up StudiesEuropean urology
researchProduct

Pancreatic Fistulae after Urologic Surgery - A Single Centre Experience.

2015

&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; To evaluate incidence, symptoms and management of postoperative pancreatic fistula (POPF) after urologic surgery based on our experience. &lt;b&gt;&lt;i&gt;Material and Methods:&lt;/i&gt;&lt;/b&gt; Database was searched for clinically evident POPF after urologic surgery between 1998 and 2014. Fistulae were graded using the POPF classification. Clinical course of every POPF patient was evaluated. &lt;b&gt;&lt;i&gt;Results:&lt;/i&gt;&lt;/b&gt; During this time, 3,200 surgeries for renal, adrenal and retroperitoneal pathologies were performed. Twelve POPF occurred postoperatively in this series. Eight fistulae were POPF grade A, 3 POPF grade …

AdultMalemedicine.medical_specialtyUrologyMalignancySepsisPancreatic FistulaYoung AdultmedicineUrologic surgeryHumansAgedRetrospective StudiesAged 80 and overbusiness.industryIncidence (epidemiology)IncidenceMiddle Agedmedicine.diseaseSurgerySingle centrePancreatic fistulaUrologic Surgical ProceduresFemalePositive Surgical MarginbusinessComplicationUrologia internationalis
researchProduct

Single center comparison of anastomotic strictures after radical perineal and radical retropubic prostatectomy.

2010

OBJECTIVES To analyze the incidence and management of anastomotic strictures (ASs) after radical perineal prostatectomy (RPP) and retropubic prostatectomy (RRP) and to identify possible predisposing factors. METHODS Between 1997 and 2007, we performed 866 RPP and 2052 RRP for localized prostate cancer. Median follow-up was 52 months (12-136). We analyzed preoperative serum prostate-specific antigen, prostate size, clinical and pathologic tumor stage, neoadjuvant hormone deprivation, previous transurethral resection of the prostate, transfusion requirement, anastomotic insufficiency, and acute urinary retention (AUR) and its subsequent management to identify possible predisposing factors for…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentUrinary BladderUrologyProstate cancerUrethraProstatemedicineHumansSuprapubic cystostomyTransurethral resection of the prostateAgedRetrospective StudiesProstatectomyUrethral Stricturebusiness.industryUrinary retentionProstatectomyAnastomosis SurgicalProstatic NeoplasmsMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureMultivariate Analysismedicine.symptombusinessRadical perineal prostatectomyRadical retropubic prostatectomyUrology
researchProduct

Reply to Athanassios Kyrgidis, Zisis Teleioudis and Konstantinos Vahtsevanos’ Letter to the Editor re: Christian Walter, Bilal Al-Nawas, Knut A. Gröt…

2009

medicine.medical_specialtyProstate cancerBisphosphonate-associated osteonecrosis of the jawLetter to the editorbusiness.industryUrologyGeneral surgerymedicineAdvanced diseasebusinessmedicine.diseaseSurgeryEuropean Urology
researchProduct

Detection of iron restriction in anaemic and non-anaemic patients: New diagnostic approaches.

2017

Objective The aim of this study was to detect iron restriction in non-anaemic patients and iron-restricted erythropoiesis (IRE) in patients with anaemia. Method Haematologic indices and biochemical markers of iron deficiency (ID) were determined using the clinically accepted cut-off level for serum ferritin of ≤30 μg/l as reference of ID. To evaluate the prevalence of iron restriction and IRE in patients with higher ferritin levels we used the thresholds of the markers of ID as reference. Results In the anaemic group 17.1% of patients with ferritin levels >30 μg/l had IRE. The number of patients with IRE declined with increasing ferritin concentration. Approximately 14% of patients without …

AdultErythrocyte IndicesMalemedicine.medical_specialtyAnemiaIron030204 cardiovascular system & hematologyGastroenterologySingle test03 medical and health sciencesYoung Adult0302 clinical medicineInternal medicineReceptors TransferrinmedicineHumansIn patientErythropoiesis030212 general & internal medicineSoluble transferrin receptorAgedAged 80 and overbiologyAnemia Iron-DeficiencyRED-CELL INDICESfungiAnemiaHematologyGeneral MedicineIron deficiencyMiddle Agedmedicine.diseaseFerritinROC CurveImmunologyFerritinsbiology.proteinErythropoiesisFemaleBiomarkersEuropean journal of haematology
researchProduct